Motif ID: Hsf2
Z-value: 1.476
Transcription factors associated with Hsf2:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
Hsf2 | ENSMUSG00000019878.7 | Hsf2 |
Activity-expression correlation:
Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Hsf2 | mm10_v2_chr10_+_57486354_57486414 | -0.33 | 2.5e-01 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 10.9 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.7 | 2.9 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.7 | 2.1 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.7 | 2.1 | GO:0019043 | establishment of viral latency(GO:0019043) |
0.7 | 2.1 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.4 | 1.5 | GO:0021586 | pons maturation(GO:0021586) |
0.4 | 1.1 | GO:2001187 | positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
0.4 | 1.8 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.4 | 1.1 | GO:0030421 | defecation(GO:0030421) |
0.3 | 1.4 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.3 | 1.0 | GO:1904139 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.3 | 1.0 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.3 | 1.3 | GO:0055099 | regulation of Cdc42 protein signal transduction(GO:0032489) response to high density lipoprotein particle(GO:0055099) platelet dense granule organization(GO:0060155) |
0.3 | 1.3 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.3 | 1.2 | GO:2000974 | negative regulation of pro-B cell differentiation(GO:2000974) |
0.3 | 0.9 | GO:0030070 | insulin processing(GO:0030070) |
0.3 | 0.9 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.3 | 0.8 | GO:0001803 | antibody-dependent cellular cytotoxicity(GO:0001788) type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
0.3 | 0.8 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
0.3 | 0.8 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.3 | 0.8 | GO:2000501 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
0.3 | 0.8 | GO:0035799 | ureter maturation(GO:0035799) |
0.3 | 0.5 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.3 | 1.0 | GO:0009597 | detection of virus(GO:0009597) |
0.2 | 1.5 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.2 | 0.7 | GO:0043465 | regulation of fermentation(GO:0043465) negative regulation of fermentation(GO:1901003) |
0.2 | 2.3 | GO:0033280 | response to vitamin D(GO:0033280) |
0.2 | 1.1 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.2 | 4.1 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.2 | 2.1 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.2 | 1.7 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.2 | 0.6 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) |
0.2 | 3.2 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.2 | 0.8 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.2 | 1.4 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.2 | 0.9 | GO:0021508 | floor plate formation(GO:0021508) floor plate morphogenesis(GO:0033505) |
0.2 | 0.6 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.2 | 0.9 | GO:0019236 | response to pheromone(GO:0019236) |
0.2 | 0.7 | GO:1900533 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.2 | 3.3 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.2 | 0.5 | GO:1904685 | positive regulation of metalloendopeptidase activity(GO:1904685) |
0.2 | 0.3 | GO:2000564 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
0.2 | 0.8 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.2 | 0.3 | GO:0010730 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
0.2 | 1.1 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.2 | 0.5 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.2 | 0.3 | GO:0021759 | globus pallidus development(GO:0021759) |
0.1 | 0.3 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.1 | 0.4 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.1 | 0.4 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
0.1 | 1.7 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.1 | 1.3 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.8 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.1 | 1.1 | GO:0032264 | IMP salvage(GO:0032264) |
0.1 | 0.5 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.1 | 0.6 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.1 | 1.0 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.5 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) positive regulation of oocyte development(GO:0060282) |
0.1 | 0.7 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.1 | 1.5 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.1 | 0.4 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.1 | 0.9 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 0.7 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.1 | 0.5 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) |
0.1 | 0.6 | GO:0044838 | cell quiescence(GO:0044838) |
0.1 | 0.8 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.1 | 1.8 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 0.3 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 0.3 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
0.1 | 0.3 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 0.3 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) peptidyl-glycine modification(GO:0018201) |
0.1 | 0.5 | GO:0097264 | self proteolysis(GO:0097264) |
0.1 | 0.6 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.3 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.1 | 0.3 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.1 | 0.3 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) phosphate ion transmembrane transport(GO:0035435) |
0.1 | 1.0 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.1 | 0.5 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.1 | 0.6 | GO:2000809 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) positive regulation of synaptic vesicle clustering(GO:2000809) |
0.1 | 0.7 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.1 | 2.2 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.1 | 0.5 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.1 | 0.5 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.5 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.1 | 1.6 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.1 | 0.8 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 0.7 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 | 0.5 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 0.3 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.1 | 1.0 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.1 | 1.3 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.1 | GO:0048636 | positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
0.1 | 0.2 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.1 | 0.3 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.1 | 0.3 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.1 | 0.6 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.1 | 0.3 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.1 | 0.3 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.1 | 1.0 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 0.2 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.1 | 0.4 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.1 | 1.1 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.1 | 0.6 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.1 | 0.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.0 | 0.4 | GO:0071800 | podosome assembly(GO:0071800) |
0.0 | 0.5 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.0 | 0.2 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.0 | 0.4 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.0 | 0.3 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
0.0 | 0.3 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.2 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.0 | 0.2 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.0 | 1.5 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.0 | 0.3 | GO:0032782 | bile acid secretion(GO:0032782) |
0.0 | 0.3 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.0 | 0.4 | GO:0015825 | L-serine transport(GO:0015825) |
0.0 | 0.0 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.0 | 2.1 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.0 | 0.2 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) response to amino acid starvation(GO:1990928) |
0.0 | 1.9 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.8 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 0.7 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.4 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.0 | 1.4 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.0 | 0.3 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.0 | 0.2 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.0 | 0.1 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.0 | 0.1 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.0 | 0.3 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.0 | 0.4 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.0 | 0.2 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.0 | 1.1 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.0 | 0.1 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.0 | 0.2 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.0 | 0.1 | GO:0097461 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.0 | 0.3 | GO:0033572 | transferrin transport(GO:0033572) |
0.0 | 0.4 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.0 | 2.4 | GO:0007601 | visual perception(GO:0007601) |
0.0 | 0.4 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.0 | 0.5 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.0 | 0.1 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.0 | 0.9 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 0.1 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.0 | 0.2 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 0.3 | GO:0030575 | nuclear body organization(GO:0030575) |
0.0 | 0.1 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.0 | 1.1 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.0 | 2.2 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
0.0 | 0.3 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.0 | 0.1 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.0 | 0.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.5 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.0 | 0.2 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.0 | 0.2 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.0 | 0.2 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 0.2 | GO:0046036 | GTP biosynthetic process(GO:0006183) CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
0.0 | 0.1 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.0 | 0.2 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.0 | 0.6 | GO:0030901 | midbrain development(GO:0030901) |
0.0 | 0.9 | GO:1902653 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.0 | 0.0 | GO:0014029 | neural crest formation(GO:0014029) |
0.0 | 0.1 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.0 | 0.1 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.1 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.0 | 0.0 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
0.0 | 0.1 | GO:1990403 | embryonic brain development(GO:1990403) |
0.0 | 0.2 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 0.3 | GO:0071625 | vocalization behavior(GO:0071625) |
0.0 | 0.1 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.0 | 0.1 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.0 | 0.1 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.0 | 0.1 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.0 | 0.2 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.1 | GO:1902913 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.0 | 0.5 | GO:0060612 | adipose tissue development(GO:0060612) |
0.0 | 0.7 | GO:0098780 | mitophagy in response to mitochondrial depolarization(GO:0098779) response to mitochondrial depolarisation(GO:0098780) |
0.0 | 0.1 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.0 | 0.4 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.0 | 0.2 | GO:0007520 | myoblast fusion(GO:0007520) |
0.0 | 0.1 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.0 | 0.1 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.0 | 0.1 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.0 | 0.6 | GO:0009408 | response to heat(GO:0009408) |
0.0 | 0.3 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 1.8 | GO:0051480 | regulation of cytosolic calcium ion concentration(GO:0051480) |
Gene overrepresentation in cellular_component category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.1 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.5 | 1.5 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.3 | 1.4 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.3 | 1.9 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.2 | 0.7 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.2 | 0.5 | GO:0042585 | germinal vesicle(GO:0042585) |
0.2 | 4.3 | GO:0005921 | gap junction(GO:0005921) |
0.2 | 0.8 | GO:0097226 | sperm mitochondrial sheath(GO:0097226) |
0.1 | 0.7 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 0.4 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.1 | 1.8 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 1.5 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.9 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 0.3 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 0.8 | GO:0005818 | aster(GO:0005818) |
0.1 | 1.1 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.2 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.1 | 0.5 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 0.6 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.9 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.7 | GO:0000243 | commitment complex(GO:0000243) |
0.1 | 0.9 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 0.2 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.1 | 0.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 1.0 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 0.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.8 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 1.4 | GO:0002102 | podosome(GO:0002102) |
0.1 | 4.6 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 0.3 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 0.3 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.1 | 1.0 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 1.0 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 0.8 | GO:0043205 | fibril(GO:0043205) |
0.1 | 0.5 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.0 | 0.2 | GO:0071556 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.0 | 0.4 | GO:0044327 | dendritic spine membrane(GO:0032591) dendritic spine head(GO:0044327) |
0.0 | 1.0 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.5 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 1.5 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 0.1 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.0 | 0.4 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.0 | 1.9 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 1.4 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 0.3 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.0 | 0.4 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.0 | 1.2 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.0 | 19.1 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.1 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.2 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.0 | 1.0 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.2 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 0.1 | GO:0000322 | storage vacuole(GO:0000322) |
0.0 | 0.2 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.0 | 1.1 | GO:0031970 | mitochondrial intermembrane space(GO:0005758) organelle envelope lumen(GO:0031970) |
0.0 | 0.2 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.0 | 0.8 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.7 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.4 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 0.5 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.2 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.0 | 0.8 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 0.8 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 1.2 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.8 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.0 | 0.5 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 1.3 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.1 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.0 | 2.3 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.1 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
Gene overrepresentation in molecular_function category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 4.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
1.0 | 10.9 | GO:0038191 | neuropilin binding(GO:0038191) |
1.0 | 2.9 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.4 | 1.3 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) |
0.4 | 1.1 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.4 | 2.9 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.4 | 1.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.3 | 1.0 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.3 | 0.8 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.3 | 0.8 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
0.3 | 0.8 | GO:0001847 | opsonin receptor activity(GO:0001847) anaphylatoxin receptor activity(GO:0004942) |
0.3 | 0.8 | GO:0005534 | galactose binding(GO:0005534) |
0.3 | 1.8 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.3 | 2.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 1.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.2 | 2.0 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.2 | 0.8 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.2 | 1.4 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.2 | 1.1 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.2 | 0.8 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.2 | 0.8 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.2 | 1.1 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.7 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 0.7 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.1 | 0.6 | GO:0001639 | PLC activating G-protein coupled glutamate receptor activity(GO:0001639) |
0.1 | 1.0 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled adenosine receptor activity(GO:0001609) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.4 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 0.9 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 1.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.7 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 1.9 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.1 | 0.5 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.1 | 0.9 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.1 | 1.1 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.1 | 0.3 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 0.6 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 0.5 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 1.9 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 0.4 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 1.7 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 0.3 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) |
0.1 | 2.2 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.8 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 1.6 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.4 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 0.3 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.2 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.1 | 1.4 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 0.3 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.1 | 1.6 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.3 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 0.7 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.4 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 0.4 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.1 | 0.5 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.1 | 0.7 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 1.5 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.3 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.1 | 0.4 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 0.8 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.7 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 0.3 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.1 | 0.3 | GO:0016151 | nickel cation binding(GO:0016151) |
0.1 | 0.2 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 0.2 | GO:0052740 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
0.1 | 0.2 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.1 | 0.7 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.2 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.0 | 1.8 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.1 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.0 | 0.2 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.0 | 2.1 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 1.3 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.1 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.0 | 0.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 2.0 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.0 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) aspartate oxidase activity(GO:0015922) |
0.0 | 0.3 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.0 | 0.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.2 | GO:0000182 | rDNA binding(GO:0000182) |
0.0 | 0.4 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.1 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
0.0 | 0.3 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 0.4 | GO:0048407 | platelet-derived growth factor receptor binding(GO:0005161) platelet-derived growth factor binding(GO:0048407) |
0.0 | 1.4 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.6 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.0 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.0 | 1.7 | GO:0019955 | cytokine binding(GO:0019955) |
0.0 | 0.5 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.5 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.4 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.1 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.0 | 0.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.1 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.0 | 0.2 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.0 | 2.3 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.2 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.2 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.0 | 0.3 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.0 | 1.2 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.3 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.0 | 0.4 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 1.8 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.9 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.3 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.0 | 1.2 | GO:0019209 | kinase activator activity(GO:0019209) |
0.0 | 0.7 | GO:0017069 | snRNA binding(GO:0017069) |
0.0 | 0.3 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.0 | 0.1 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.0 | 0.1 | GO:0008392 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 1.1 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.3 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.0 | 0.3 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.8 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.1 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) RNA polymerase II transcription corepressor binding(GO:0001226) |
0.0 | 0.5 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.1 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.0 | 0.1 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.0 | GO:0042731 | PH domain binding(GO:0042731) |
0.0 | 0.3 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.4 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 1.0 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.0 | 0.1 | GO:0008758 | thiamine-pyrophosphatase activity(GO:0004787) UDP-2,3-diacylglucosamine hydrolase activity(GO:0008758) dATP pyrophosphohydrolase activity(GO:0008828) dihydroneopterin monophosphate phosphatase activity(GO:0019176) dihydroneopterin triphosphate pyrophosphohydrolase activity(GO:0019177) dTTP diphosphatase activity(GO:0036218) phosphocholine hydrolase activity(GO:0044606) |
0.0 | 0.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |